ISRCTN32281812已完成未知
Effectiveness of a Pharmacist-driven Intervention in COPD (EPIC2): a randomized controlled trial
The Health Research Foundation0 个研究点目标入组 200 人开始时间: 2017年5月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Physician-diagnosed COPD
- •2. Age =40 years at trial enrollment
- •3. Ability to answer questionnaires in English
排除标准
- •1. Severe disease defined as a known Forced Expiratory Volume in 1 second (FEV1)/ Forced Vital Capacity (FVC) of <30%
- •2. A diagnosis of dementia or a prescription for cholinesterase inhibitors
- •3. A terminal illness
- •4. Participation in another clinical trial
- •5. Do not provide consent
研究者
相似试验
尚未招募
Unknown
Efficacy of pharmacist intervention for a patient who takes incretin modulator.Diabetes mellitusJPRN-UMIN000050659Chiba Pharmaceutical Association60
尚未招募
不适用
Pharmaceutical care for asthma patients dependent on their disease controlAsthma disease control (CARAT, pharmacy dispensing data), medication adherence (MARS, pharmacy dispensing data), inhalation technique (checklist)NL-OMON24520Radboud university medical centre, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands80
招募中
Unknown
Outcome Measure of Pharmacist-led Intervention for Chronic Kidney Disease PatientsChronic kidney diseaseJPRN-UMIN000049914Kinjo Gakuin University50
招募中
不适用
Impact of clinical pharmacist interventions on the clinical outcome of patients with Bipolar Disorder (BD)Bipolar DisorderIRCT20210307050613N1Tehran University of Medical Sciences112
已完成
Unknown
Impact of pharmacist led interventions for drug related problems among chronic kidney disease patients: A randomized control trialchronic kidney diseaseDiabetesACTRN12623000370606Dr. Inayat Ur Rehman (PhD Clinical Pharmacy)100